American Society of Hematology

ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.

Need to speak with an expert? Complete our Request An Expert form.

To be added to ASH's press release distribution list, contact Alicia Davids at adavids@hematology.org.

Latest Press Releases

  • Study: Race Influences Warfarin Dose May 29, 2015

    A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology (ASH), proposes race-specific equations to help clinicians better calculate warfarin dosage.

  • Study: Blood Thinner Safe for Cancer Patients with Brain Metastases May 18, 2015

    Cancer patients with brain metastases who develop blood clots may safely receive blood thinners without increased risk of dangerous bleeding, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

  • ASH Agenda for Hematology Research Identifies Top Priorities for Scientific Discovery Apr 29, 2015

    The American Society of Hematology, the world’s largest professional society committed to the study and treatment of blood disorders, today issued a report urging scientists and funding institutions to coordinate their efforts around six research areas with the strongest potential to make a dramatic impact on the care of patients with a wide range of diseases.

View all